Study: Pediatric type 1 diabetes families prefer virtual care and telehealth
September 14th 2023Surveys collected for a study published in the Canadian Journal of Diabetes revealed that desire for telehealth care amid pediatric diabetes families increased from the early onset of the COVID-19 pandemic, to more than 1 year later.
The current state of transgender reproductive care in the United States
September 14th 2023In this interview originally conducted by our sister publication Contemporary OB/GYN, Marci Bowers, MD, shares the biggest takeaways from her presentation on transgender reproductive care, presented at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois.
Developing biomarkers for gut and neurological, cognitive functioning associations in children
September 7th 2023In this Contemporary Pediatrics interview, Rob Knight, PhD, discusses translating adult studies into children to determine gut microbiome biomarkers, and how they are associated with neurological and cognitive conditions.
CDC issues health advisory alert after increases in RSV activity
September 6th 2023Due to increased RSV activity observed in Southeastern regions of the United States, the Centers for Disease Control and Prevention (CDC) has issued an official Health Alert Network Health Advisory. The CDC recommends that clinicians prepare to implement recently FDA-approved prevention methods.
FDA-cleared tool could assist in diagnosing autism
September 6th 2023The EarliPoint Evaluation has demonstrated positive phase 3 trial results, aiding in autism diagnosis and assessment in children aged 16 to 30 months. Warren Jones, PhD, chief scientific officer and cofounder of EarliTec Diagnostics, Inc., discusses the eye-tracking tool, how it is currently being used, and what could be in store for the future.
FDA sends warning letters to infant formula manufacturers after violations
August 31st 2023The FDA inspected each company’s facilities, in which the agency issued inspectional observations and exercised oversight of each firm as recalls were initiated in December 2022, February 2023, and March 2023, respectively, for the removal of products potentially contaminated with Cronobacter sakazakii from the marketplace.